- Anthem: Morgan Stanley downgrades to equal-weight from overweight. PT jumps 16% to $533.
- Brixmor Property: J.P. Morgan upgrades to overweight from neutral. PT jumps 27% to $25.
- Celanese Corporation: Alembic Global Advisors lowers price target to $165 from $200, maintains overweight rating.
- Ceres Power: Goldman Sachs upgrades from sell to buy targeting GBp 700.
- Cigna: Morgan Stanley upgrades to overweight from equal-weight. PT up 17% to $296.
- Corteva: BofA Securities raises price target to $57 from $51, maintains underperform rating.
- CRISPR Therapeutics: Piper Sandler adjusts price target to $121 from $115, reiterates overweight rating.
- Equity Residential: RBC Capital Markets upgrades to outperform from sector perform. PT rises 11% to $79.
- Johnson & Johnson: Daiwa Securities initiated coverage with a recommendation of outperform. PT up 4% to $180.
- Kroger: MKM Partners raises price target to $55 from $48, maintains neutral rating.
- Lennar Corporation: Barclays adjusts price target to $85 from $93, keeps equalweight rating.
- PNM Resources: Mizuho Securities upgrades to buy from neutral. PT up 16% to $52.
- Medical properties: J.P. Morgan downgrades to neutral from overweight. PT rises 23% to $18.
- NatWest: Jefferies upgrades from hold to buy targeting GBp 359.
- Rogers Communications: Canaccord upgrades to buy from hold, lowers price target to CA$69 from CA$71.
- Sage Group: Jefferies remains Buy with a price target reduced from GBp 890 to GBp 740.
- Smurfit Kappa: Jefferies upgrades from hold to buy targeting GBp 3700.
- The Home Depot: Evercore ISI adjusts price target to $320 from $335, maintains outperform rating.
- The Kraft Heinz Company: BMO Capital upgrades to outperform from market perform; price target is $46.
- The Sherwin-Williams Company: Evercore ISI adjusts price target to $280 from $305, maintains outperform rating.
- Veeva: Guggenheim initiates coverage with buy rating, $252 price target.
- Vodafone: Barclays moves from Overweight to Equal-Weight in line with GBp 140 target.
- Welltower: J.P. Morgan upgrades to overweight from neutral. PT up 13% to $89.